Phase 2 Mild Cognitive Impairment trials recruiting now

All Mild Cognitive Impairment trials, every phase

Other phases for Mild Cognitive Impairment

Phase 2 Mild Cognitive Impairment trials

• A Study of NTRX-07 in Participants With Alzheimer's Disease
  NCT07058688 · Phase: Phase 2 · Ages: 65 Years to 80 Years · Sex: All (male and female) · 6 locations
• CBD for Individuals at Risk for Alzheimer's Disease
  NCT05822362 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · 1 location
• COMMETS- Combination MCI Metabolic Syndrome
  NCT06072963 · Phase: Phase 2 · Ages: 60 Years to 90 Years · Sex: All (male and female) · 1 location
• Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
  NCT07512362 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 1 location
• Novel Augmentation of DAOIB and Antioxidant for Early Dementia
  NCT06467539 · Phase: Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• Senicapoc in Alzheimer's Disease
  NCT04804241 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · 2 locations
• Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
  NCT05565833 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
  NCT07395960 · Phase: Phase 1, Phase 2 · Ages: 60 Years to 75 Years · Sex: All (male and female) · 1 location
• Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
  NCT04601038 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · 1 location
• Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
  NCT07012993 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
  NCT04643327 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• rTMS to Improve Cognition in Parkinson's
  NCT03836950 · Phase: Phase 1, Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · 2 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.